Skip to main content
Steven Cannady, MD, Otolaryngology (ENT), Philadelphia, PA, Hospital of the University of Pennsylvania

StevenBernardCannadyMD

Otolaryngology (ENT) Philadelphia, PA

Head & Neck Microvascular Surgery, Head & Neck Oncologic Surgery

Assistant Professor, Otorhinolaryngology/Head & Neck Surgery, Perelman School of Medicine

Dr. Cannady is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Cannady's full profile

Already have an account?

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Otolaryngology - Head and Neck Surgery, 2003 - 2008
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 2002

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2008 - Present
  • PA State Medical License
    PA State Medical License 2013 - 2024
  • NY State Medical License
    NY State Medical License 2009 - 2014
  • OH State Medical License
    OH State Medical License 2002 - 2008
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • Teacher of the year University of Pennsylvania department of otorhinolarygology, 2016
  • Teacher of the year SUNY downstate department of otolaryngology, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Factors Associated with Complications in Total Laryngectomy Without Microvascular Reconstruction  
    Jason G Newman, Jason A Brant, Sameep K Kadakia, Steven B Cannady, Head & Neck

Press Mentions

  • Is Head & Neck Surgery in the Super-Old a Bad Idea?
    Is Head & Neck Surgery in the Super-Old a Bad Idea?October 9th, 2019
  • Newly Approved Spinal Muscle Atrophy Treatment Zolgensma Is Based on Delivery System Discovered by Penn Gene Therapy Pioneer
    Newly Approved Spinal Muscle Atrophy Treatment Zolgensma Is Based on Delivery System Discovered by Penn Gene Therapy PioneerMay 24th, 2019

Grant Support

  • Virally-Induced Stat-1, STAT-3 And STAT-6National Center For Research Resources2006

Professional Memberships

Hospital Affiliations